This company has been marked as potentially delisted and may not be actively trading. CAMP4 Therapeutics (CAMP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSustainabilityTrendsBuy This Stock CAMP4 Therapeutics Short Interest DataCAMP4 Therapeutics (CAMP) has a short interest of 50,000 shares, representing 3.14% of the float (the number of shares available for trading by the public). This marks a -20.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 161,274 shares to cover all short positions.Current Short Interest50,000 sharesPrevious Short Interest62,900 sharesChange Vs. Previous Month-20.51%Dollar Volume Sold Short$133.50 thousandShort Interest Ratio0.3 Days to CoverLast Record DateMay 31, 2024Outstanding Shares20,160,000 sharesFloat Size1,590,000 sharesShort Percent of Float3.14%Today's Trading Volume58,479 sharesAverage Trading Volume161,274 sharesToday's Volume Vs. Average36% Short Selling CAMP4 Therapeutics? Sign up to receive the latest short interest report for CAMP4 Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCAMP Short Interest Over TimeCAMP Days to Cover Over TimeCAMP Percentage of Float Shorted Over Time CAMP4 Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202450,000 shares $133.50 thousand -20.5%3.1%0.3 $2.67 5/15/202462,900 shares $227.70 thousand -14.8%4.0%2.2 $3.62 4/30/202473,800 shares $239.11 thousand -19.6%4.7%1.3 $3.24 4/15/202491,800 shares $290.09 thousand +2.3%5.8%0.7 $3.16 3/31/202489,700 shares $290.63 thousand -13.1%5.7%0.6 $3.24 3/15/2024103,200 shares $298.25 thousand -10.3%6.5%0.7 $2.89 2/29/2024115,100 shares $337.24 thousand -23.8%7.3%0.8 $2.93 2/15/2024151,000 shares $573.80 thousand +662.6%9.6%1.1 $3.80 1/31/202419,800 shares $63.57 thousand +17.2%1.3%0.2 $3.21 1/15/2024388,100 shares $79.56 thousand +33.4%N/A0.7 $0.21 Get the Latest News and Ratings for CAMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CAMP4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023290,900 shares $73.02 thousand -19.7%N/A0.5 $0.25 12/15/2023362,300 shares $105.07 thousand -4.2%N/A0.7 $0.29 11/30/2023378,100 shares $121.86 thousand -34.6%N/A0.7 $0.32 11/15/2023578,500 shares $230.71 thousand +19.7%N/A1.1 $0.40 10/31/2023483,200 shares $116.45 thousand -22.5%N/A0.9 $0.24 10/15/2023623,700 shares $145.95 thousand +19.8%N/A1.2 $0.23 9/30/2023520,700 shares $211.20 thousand +14.2%N/A0.9 $0.41 9/15/2023455,800 shares $264.36 thousand +12.4%N/A0.8 $0.58 8/31/2023405,400 shares $248.67 thousand -28.3%N/A1 $0.61 8/15/2023565,700 shares $405.15 thousand -10.2%N/A1.4 $0.72 7/31/2023629,700 shares $585.62 thousand -36.0%N/A1.7 $0.93 7/15/2023984,100 shares $934.90 thousand +47.4%N/A2.6 $0.95 6/30/2023667,700 shares $707.76 thousand -8.2%N/A2.2 $1.06 6/15/2023727,100 shares $1.34 million -2.0%N/A3.6 $1.84 5/31/2023742,200 shares $1.31 million -2.7%N/A4.7 $1.76 5/15/2023762,800 shares $1.34 million +0.2%N/A4.9 $1.76 4/30/2023761,200 shares $1.93 million -7.5%N/A5 $2.54 4/15/2023822,500 shares $2.57 million -6.3%2.3%5.2 $3.13 3/31/2023877,600 shares $3.15 million -27.5%2.5%5.7 $3.59 3/15/20231,210,000 shares $3.96 million -2.4%3.4%6.4 $3.27 2/28/20231,240,000 shares $5.29 million -10.8%3.6%5.9 $4.27 2/15/20231,390,000 shares $6.34 million +3.0%4.0%6.5 $4.56 1/31/20231,350,000 shares $6.25 million +5.5%3.9%5.5 $4.63 1/15/20231,280,000 shares $6.41 million -7.3%3.6%5 $5.01 12/30/20221,380,000 shares $6.18 million -2.8%N/A4.3 $4.48 12/15/20221,420,000 shares $5.41 million +2.2%N/A3.3 $3.81 11/30/20221,390,000 shares $5.02 million -4.8%N/A2.3 $3.61 11/15/20221,460,000 shares $5.46 million -18.9%N/A2.2 $3.74 10/31/20221,800,000 shares $6.84 million +5.3%5.2%2.7 $3.80 10/15/20221,710,000 shares $5.56 million -2.3%4.9%2.4 $3.25Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 9/30/20221,750,000 shares $6.72 million -8.9%N/A2.6 $3.84 9/15/20221,920,000 shares $9.56 million +1.1%5.5%2.4 $4.98 8/31/20221,900,000 shares $11.74 million +15.9%5.5%3.1 $6.18 8/15/20221,640,000 shares $9.51 million +8.6%4.7%3 $5.80 7/31/20221,510,000 shares $7.11 million -10.1%4.4%2.9 $4.71 7/15/20221,680,000 shares $7.11 million +33.3%4.8%3.3 $4.23 6/30/20221,260,000 shares $5.25 million -48.2%3.6%2.6 $4.17 6/15/20222,430,000 shares $15.07 million -1.2%6.9%6.1 $6.20 5/31/20222,460,000 shares $17.86 million +3.4%7.0%9.4 $7.26 5/15/20222,380,000 shares $13.07 million +13.9%6.8%9.4 $5.49 4/30/20222,090,000 shares $11.43 million +22.9%6.0%8.1 $5.47 4/15/20221,700,000 shares $10.35 million -15.4%4.8%6.5 $6.09 3/31/20222,010,000 shares $14.69 million -0.5%5.7%7.2 $7.31 3/15/20222,020,000 shares $13.61 million +20.2%5.8%6 $6.74 2/28/20221,680,000 shares $11.86 million +24.4%4.8%5 $7.06 2/15/20221,350,000 shares $8.94 million +8.9%3.9%4.1 $6.62 1/31/20221,240,000 shares $7.37 million +35.8%3.6%4.1 $5.94 1/15/2022913,200 shares $5.64 million +59.4%2.6%3.3 $6.18 12/31/2021573,000 shares $4.05 million +25.1%1.6%2.5 $7.06 12/15/2021458,100 shares $4.42 million -20.7%1.3%2.5 $9.64 11/30/2021577,300 shares $5.30 million +9.4%1.7%4 $9.18 11/15/2021527,500 shares $5.39 million -7.1%1.5%3.9 $10.21 10/29/2021567,500 shares $5.46 million -24.6%1.6%4.4 $9.62 10/15/2021752,800 shares $7.54 million -11.1%2.2%5.6 $10.02 9/30/2021846,300 shares $8.42 million +4.1%2.4%5.8 $9.95 9/15/2021813,200 shares $8.73 million -17.4%2.4%4.4 $10.73 8/31/2021984,300 shares $11.16 million +5.1%2.9%5.6 $11.34 8/13/2021936,800 shares $11.03 million -5.6%2.7%5 $11.77 7/30/2021992,200 shares $12.04 million +1.6%2.9%4.7 $12.13 7/15/2021976,200 shares $11.72 million +1.7%2.8%4.1 $12.01 6/30/2021959,600 shares $12.21 million +24.7%2.8%4.1 $12.72 6/15/2021769,700 shares $10.83 million -4.7%2.3%3.8 $14.07 5/28/2021807,300 shares $11.20 million +5.1%2.4%4.2 $13.87 5/14/2021768,200 shares $9.55 million +5.6%N/A3.8 $12.43 4/30/2021727,300 shares $10.19 million -17.4%N/A4 $14.01 4/15/2021880,800 shares $10.34 million -7.2%N/A4.9 $11.74 3/31/2021949,500 shares $10.19 million -12.9%N/A5.3 $10.73 3/15/20211,090,000 shares $13.06 million +5.8%N/A5 $11.98 2/26/20211,030,000 shares $11.74 million -6.4%N/A4.4 $11.40 2/12/20211,100,000 shares $12.39 million +1.9%N/A4.7 $11.26 1/29/20211,080,000 shares $11.08 million -1.8%N/A4.6 $10.26 1/15/20211,100,000 shares $11.67 million -14.7%N/A4.6 $10.61 12/31/20201,290,000 shares $12.73 million +6.6%N/A5.6 $9.87 12/15/20201,210,000 shares $12.81 million +3.4%N/A5.2 $10.59 11/30/20201,170,000 shares $10.94 million -10.0%N/A5.5 $9.35 11/15/20201,300,000 shares $11.00 million -6.5%N/A6 $8.46 10/30/20201,390,000 shares $10.27 million +27.5%N/A6.2 $7.39 10/15/20201,090,000 shares $8.34 million +0.9%N/A4.6 $7.65 9/30/20201,080,000 shares $7.77 million -12.9%N/A4.4 $7.19 9/15/20201,240,000 shares $10.55 million -6.1%3.7%4.5 $8.51Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 8/31/20201,320,000 shares $10.78 million -11.4%4.0%4.3 $8.17 8/14/20201,490,000 shares $14.02 million -8.6%4.5%4.4 $9.41 7/31/20201,630,000 shares $12.84 million -5.8%4.9%4.2 $7.88 7/15/20201,730,000 shares $13.04 million -7.5%N/A4.2 $7.54 CAMP Short Interest - Frequently Asked Questions What is CAMP4 Therapeutics' current short interest? Short interest is the volume of CAMP4 Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 50,000 shares of CAMP short. 3.14% of CAMP4 Therapeutics' shares are currently sold short. Learn More on CAMP4 Therapeutics' current short interest. What is a good short interest percentage for CAMP4 Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.14% of CAMP4 Therapeutics' floating shares are currently sold short. Is CAMP4 Therapeutics' short interest increasing or decreasing? CAMP4 Therapeutics saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 50,000 shares, a decrease of 20.5% from the previous total of 62,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CAMP4 Therapeutics' float size? CAMP4 Therapeutics currently has issued a total of 20,160,000 shares. Some of CAMP4 Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CAMP4 Therapeutics currently has a public float of 1,590,000 shares. How does CAMP4 Therapeutics' short interest compare to its competitors? 3.14% of CAMP4 Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to CAMP4 Therapeutics: KVH Industries, Inc. (0.50%), Comtech Telecommunications Corp. (4.20%), Aware, Inc. (1.13%), Cisco Systems, Inc. (1.27%), QUALCOMM Incorporated (1.91%), Palo Alto Networks, Inc. (4.09%), Motorola Solutions, Inc. (1.26%), F5, Inc. (3.24%), Juniper Networks, Inc. (2.40%), Ciena Corporation (4.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Corporation ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors Company ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply Company ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short CAMP4 Therapeutics stock? Short selling CAMP is an investing strategy that aims to generate trading profit from CAMP4 Therapeutics as its price is falling. CAMP shares are trading down $2.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CAMP4 Therapeutics? A short squeeze for CAMP4 Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CAMP, which in turn drives the price of the stock up even further. How often is CAMP4 Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CAMP, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies KVH Industries Short Interest Data Comtech Telecommunications Short Interest Data Aware Short Interest Data Cisco Systems Short Interest Data QUALCOMM Short Interest Data Palo Alto Networks Short Interest Data Motorola Solutions Short Interest Data F5 Short Interest Data Juniper Networks Short Interest Data Ciena Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CAMP) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAMP4 Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CAMP4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
